Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

FORCE | OlympiA – Olaparib Adjuvant Therapy for BRCA-related Breast Cancer,

OlympiA is a phase III clinical trial looking at the safety and effectiveness of olaparib for women with stage 2 or 3 breast cancer with a BRCA mutation …, OlympiA is a phase III clinical trial looking at the safety and effectiveness of olaparib for women with stage 2 or 3 breast cancer with a BRCA mutation …, Read More

Scroll to Top